Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spruce Biosciences (SPRB) Other Non-Current Assets (2022 - 2025)

Spruce Biosciences (SPRB) has disclosed Other Non-Current Assets for 4 consecutive years, with $243000.0 as the latest value for Q4 2025.

  • Quarterly Other Non-Current Assets rose 252.17% to $243000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $243000.0 through Dec 2025, up 252.17% year-over-year, with the annual reading at $243000.0 for FY2025, 252.17% up from the prior year.
  • Other Non-Current Assets for Q4 2025 was $243000.0 at Spruce Biosciences, up from $62000.0 in the prior quarter.
  • The five-year high for Other Non-Current Assets was $678000.0 in Q1 2022, with the low at $62000.0 in Q3 2025.
  • Average Other Non-Current Assets over 4 years is $420687.5, with a median of $533500.0 recorded in 2023.
  • Peak annual rise in Other Non-Current Assets hit 252.17% in 2025, while the deepest fall reached 88.32% in 2025.
  • Over 4 years, Other Non-Current Assets stood at $640000.0 in 2022, then decreased by 9.06% to $582000.0 in 2023, then tumbled by 88.14% to $69000.0 in 2024, then soared by 252.17% to $243000.0 in 2025.
  • According to Business Quant data, Other Non-Current Assets over the past three periods came in at $243000.0, $62000.0, and $64000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.